What question did this study set out to answer?

The research aims to assess the diagnostic performance of FDG-PET/MRI for staging in head-and-neck cancers during different phases of treatment.

April 28, 2026Open Access

View Full Paper

18FFDG-PET/MRI Performance in Head-and-Neck Cancers at Initial Staging, Restaging and Follow Up

NPNadya PyatigorskayaCentre National de la Recherche Scientifique SBSarah BoughdadCentre National de la Recherche Scientifique GBGeraldine BeraCentre National de la Recherche Scientifique

Key Points

The research aims to assess the diagnostic performance of FDG-PET/MRI for staging in head-and-neck cancers during different phases of treatment.
Evaluated diagnostic accuracy of FDG-PET/MRI during initial staging, restaging, and follow-up.
Analyzes T and N-staging performance.
FDG-PET/MRI showed excellent diagnostic accuracy in T and N-staging across all phases.
Performance remained consistent at initial staging, restaging, and follow-up.

Abstract

18FFDG-PET/MR has excellent diagnostic performances for both T and N-staging in HNC, showing a good accuracy whether it was at initial staging, restaging or during the follow-up.

Demander à l'IA

Bookmark

View Full Paper

Demander à l'IA

Bookmark

View Full Paper

18FFDG-PET/MRI Performance in Head-and-Neck Cancers at Initial Staging, Restaging and Follow Up

Key Points

Abstract

Cite This Study

Also Consider

Also Consider